The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the ...

The 2026 update reflects rapid advancements in diabetes care, with a strong emphasis on personalized treatment, technology ...

Today, the American Diabetes Association (R) (ADA) released the "Standards of Care in Diabetes--2026" (Standards of Care), the gold standard in evidence-based guidelines for diagnosing and managing ...

Boost, a nutritional beverage brand, is teaming up with the American Diabetes Association to help increase awareness about ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A growing number of diabetes technology companies are ...

The American Diabetes Association and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity and metabolic dysfunction. The ...

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...

It’s another high-profile partnership for IBM Watson Health. Sunday at the American Diabetes Association’s 76th annual Scientific Sessions meeting in New Orleans, IBM announced that it was teaming up ...

Though continuous glucose monitors have long been more widely used among people with Type 1 diabetes, new research has increasingly shown that the Type 2 population can majorly benefit from CGM use, ...

NEW YORK — The American Diabetes Association and the American Heart Association have announced a joint, multiyear partnership to raise awareness about the increased risk for cardiovascular disease ...

The 2019 Standards of Care reflect an ongoing collaboration between the American Diabetes Association and the American College of Cardiology. The growing connection between treatment for diabetes and ...

The revised ADA guidelines state that 2 large clinical trials justify consideration of empagliflozin or liraglutide in patients with established cardiovascular disease to reduce the risk of death. ADA ...